126 related articles for article (PubMed ID: 3105236)
1. Does centralized treatment of cystic fibrosis increase the risk of Pseudomonas aeruginosa infection?
Pedersen SS; Jensen T; Pressler T; Høiby N; Rosendal K
Acta Paediatr Scand; 1986 Sep; 75(5):840-5. PubMed ID: 3105236
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in the Danish Cystic Fibrosis Centre.
Zembrzuska-Sadkowska E; Sneum M; Ojeniyi B; Heiden L; Høiby N
J Hosp Infect; 1995 Jan; 29(1):1-7. PubMed ID: 7738336
[TBL] [Abstract][Full Text] [Related]
3. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
Hansen CR; Pressler T; Høiby N
J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
[TBL] [Abstract][Full Text] [Related]
4. Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy.
Cigana C; Melotti P; Baldan R; Pedretti E; Pintani E; Iansa P; De Fino I; Favari F; Bergamini G; Tridello G; Cirillo DM; Assael BM; Bragonzi A
BMC Microbiol; 2016 Jul; 16(1):142. PubMed ID: 27400750
[TBL] [Abstract][Full Text] [Related]
5. Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center.
Lee TW; Brownlee KG; Denton M; Littlewood JM; Conway SP
Pediatr Pulmonol; 2004 Feb; 37(2):104-10. PubMed ID: 14730654
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic.
Zimakoff J; Høiby N; Rosendal K; Guilbert JP
J Hosp Infect; 1983 Mar; 4(1):31-40. PubMed ID: 6190882
[TBL] [Abstract][Full Text] [Related]
7. Staphylococcus aureus in the airways of cystic fibrosis patients - A retrospective long-term study.
Schwerdt M; Neumann C; Schwartbeck B; Kampmeier S; Herzog S; Görlich D; Dübbers A; Große-Onnebrink J; Kessler C; Küster P; Schültingkemper H; Treffon J; Peters G; Kahl BC
Int J Med Microbiol; 2018 Aug; 308(6):631-639. PubMed ID: 29501453
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients.
Schelstraete P; Van Daele S; De Boeck K; Proesmans M; Lebecque P; Leclercq-Foucart J; Malfroot A; Vaneechoutte M; De Baets F
Eur Respir J; 2008 Apr; 31(4):822-9. PubMed ID: 18094014
[TBL] [Abstract][Full Text] [Related]
9. Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients.
Høiby N; Pedersen SS
Acta Paediatr Scand; 1989 May; 78(3):395-404. PubMed ID: 2787093
[TBL] [Abstract][Full Text] [Related]
10. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
[TBL] [Abstract][Full Text] [Related]
11. Effective prevention of Pseudomonas aeruginosa cross-infection at a cystic fibrosis centre - results of a 10-year prospective study.
Wiehlmann L; Cramer N; Ulrich J; Hedtfeld S; Weissbrodt H; Tümmler B
Int J Med Microbiol; 2012 Mar; 302(2):69-77. PubMed ID: 22196973
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients.
Jelsbak L; Johansen HK; Frost AL; Thøgersen R; Thomsen LE; Ciofu O; Yang L; Haagensen JA; Høiby N; Molin S
Infect Immun; 2007 May; 75(5):2214-24. PubMed ID: 17261614
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
[TBL] [Abstract][Full Text] [Related]
14. How and why to monitor Pseudomonas aeruginosa infections in the long term at a cystic fibrosis centre.
Kalferstova L; Vilimovska Dedeckova K; Antuskova M; Melter O; Drevinek P
J Hosp Infect; 2016 Jan; 92(1):54-60. PubMed ID: 26597636
[TBL] [Abstract][Full Text] [Related]
15. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
Hansen CR; Pressler T; Hoiby N; Johansen HK
J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and persistence of polyagglutinable Pseudomonas aeruginosa in isolates from cystic fibrosis patients.
Ojeniyi B; Høiby N; Rosdahl VT
APMIS; 1991 Feb; 99(2):187-95. PubMed ID: 1900422
[TBL] [Abstract][Full Text] [Related]
17. Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients.
Pedersen SS; Jensen T; Høiby N; Koch C; Flensborg EW
Acta Paediatr Scand; 1987 Nov; 76(6):955-61. PubMed ID: 3425313
[TBL] [Abstract][Full Text] [Related]
18. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis.
Kidd TJ; Soares Magalhães RJ; Paynter S; Bell SC;
Lancet Respir Med; 2015 Aug; 3(8):640-50. PubMed ID: 26208994
[TBL] [Abstract][Full Text] [Related]
19. Cross-infections with Pseudomonas aeruginosa in patients with cystic fibrosis attending the Warsaw Centre.
Milczewska J; Wołkowicz T; Zacharczuk K; Kwiatkowska M
Dev Period Med; 2015; 19(1):60-5. PubMed ID: 26003071
[TBL] [Abstract][Full Text] [Related]
20. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
